We are proud to announce that Dr. Paul Dato, MD, Director at Unio’s Cancer Center of Excellence, has been invited to share his insights as a Urologist, together with Dr. Rana McKay from UCSD, on the use of Darolutamide for managing metastatic hormone-sensitive prostate cancer. Please click here or on the image below to view the video and read the full article.